James M. Wilson | |
|---|---|
| Alma mater | Albion College, University of Michigan |
| Known for | Gene Therapy |
| Scientific career | |
| Institutions | Perelman School of Medicine |
| Doctoral advisor | William N. Kelley |
James M. Wilson is an American biomedical researcher and CEO of two biotech companies, Gemma Biotherapeutics and Franklin Biolabs, focused on gene therapies.[1] He previously served as the Director of the Gene Therapy Program, Rose H. Weiss Professor and Director of the Orphan Disease Center, and Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.[2] Previously, he held the John Herr Musser endowed professorship at the Perelman School of Medicine.[3]
- ^ George, John (1 Aug 2024). "Dr. Jim Wilson, gene therapy pioneer, leaves Penn to focus on two startups". Philadelphia Business Journal.
- ^ "University of Pennsylvania Gene Therapy Program | Our Team". gtp.med.upenn.edu. Retrieved 2018-09-28.
- ^ "John Herr Musser Professorship of Research Medicine | Endowed Professorships | Perelman School of Medicine at the University of Pennsylvania". www.med.upenn.edu.